MA26425A1 - Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant - Google Patents

Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant

Info

Publication number: MA26425A1
Authority: MA; Morocco
Prior art keywords: preparation; pharmaceutical compositions; compositions containing; lactam derivatives; lactam
Prior art date: 1996-03-29

Application number

MA24535A

Other languages

English (en)

Inventor

R Howard Harry

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-03-29

Filing date

1997-03-26

Publication date

2004-12-20

1997-03-26 Application filed by Pfizer filed Critical Pfizer

2004-12-20 Publication of MA26425A1 publication Critical patent/MA26425A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms

MA24535A 1996-03-29 1997-03-26 Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant MA26425A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US1513496P	1996-03-29	1996-03-29

Publications (1)

Publication Number	Publication Date
MA26425A1 true MA26425A1 (fr)	2004-12-20

Family

ID=21769713

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA24535A MA26425A1 (fr)	1996-03-29	1997-03-26	Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant

Country Status (40)

Country	Link
US (2)	US6462048B2 (fr)
EP (1)	EP0894085B1 (fr)
JP (1)	JP3118467B2 (fr)
KR (1)	KR100305071B1 (fr)
CN (1)	CN1128788C (fr)
AP (1)	AP824A (fr)
AR (1)	AR006390A1 (fr)
AT (1)	ATE302182T1 (fr)
AU (1)	AU706839B2 (fr)
BG (1)	BG64176B1 (fr)
BR (1)	BR9708581A (fr)
CA (1)	CA2249603A1 (fr)
CO (1)	CO4650033A1 (fr)
CZ (1)	CZ293628B6 (fr)
DE (1)	DE69733996T2 (fr)
DZ (1)	DZ2198A1 (fr)
EA (1)	EA001485B1 (fr)
ES (1)	ES2246058T3 (fr)
HK (1)	HK1019446A1 (fr)
HN (1)	HN1997000023A (fr)
HR (1)	HRP970175A2 (fr)
HU (1)	HUP9902160A3 (fr)
ID (1)	ID17781A (fr)
IL (1)	IL125377A (fr)
IS (1)	IS4813A (fr)
MA (1)	MA26425A1 (fr)
MY (1)	MY118498A (fr)
NO (1)	NO312957B1 (fr)
NZ (1)	NZ325914A (fr)
OA (1)	OA10879A (fr)
PL (1)	PL329170A1 (fr)
SK (1)	SK131498A3 (fr)
TN (1)	TNSN97056A1 (fr)
TR (1)	TR199801929T2 (fr)
TW (1)	TW413679B (fr)
UA (1)	UA70284C2 (fr)
UY (1)	UY24498A1 (fr)
WO (1)	WO1997036867A1 (fr)
YU (1)	YU11997A (fr)
ZA (1)	ZA972690B (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH041367U (fr) *	1990-04-13	1992-01-08
US5880141A (en) *	1995-06-07	1999-03-09	Sugen, Inc.	Benzylidene-Z-indoline compounds for the treatment of disease
US6147106A (en)	1997-08-20	2000-11-14	Sugen, Inc.	Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6906093B2 (en)	1995-06-07	2005-06-14	Sugen, Inc.	Indolinone combinatorial libraries and related products and methods for the treatment of disease
US6696448B2 (en)	1996-06-05	2004-02-24	Sugen, Inc.	3-(piperazinylbenzylidenyl)-2-indolinone compounds and derivatives as protein tyrosine kinase inhibitors
US6423708B1 (en) *	1996-09-30	2002-07-23	Pfizer Inc	Aralkyl and aralkylidene heterocyclic lactams and imides
GB9718913D0 (en)	1997-09-05	1997-11-12	Glaxo Group Ltd	Substituted oxindole derivatives
US6531502B1 (en)	1998-01-21	2003-03-11	Sugen, Inc.	3-Methylidenyl-2-indolinone modulators of protein kinase
DE19830201A1 (de) *	1998-07-07	2000-01-13	Boehringer Ingelheim Pharma	Mittel mit antidepressiver Wirkung
WO2000006162A1 (fr) *	1998-07-27	2000-02-10	Boehringer Ingelheim Pharma Kg	Agents a effet antidepresseur, comprenant du pramipexol et un autre antidepresseur
GB9904933D0 (en)	1999-03-04	1999-04-28	Glaxo Group Ltd	Compounds
US6624171B1 (en)	1999-03-04	2003-09-23	Smithkline Beecham Corporation	Substituted aza-oxindole derivatives
US6492398B1 (en)	1999-03-04	2002-12-10	Smithkline Beechman Corporation	Thiazoloindolinone compounds
ATE276249T1 (de) *	1999-12-29	2004-10-15	Pfizer Prod Inc	Optisch aktive 3-((2-piperazinyl-phenyl)methyl)-1-(4-(trifluor methyl)-phenyl)-2-pyrrolidinone als selektive 5-ht1d rezeptor antagonisten
US6620818B1 (en)	2000-03-01	2003-09-16	Smithkline Beecham Corporation	Method for reducing the severity of side effects of chemotherapy and/or radiation therapy
WO2003031438A1 (fr)	2001-10-10	2003-04-17	Sugen, Inc.	Derives de 3-[4-(substitue heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone utiles comme inhibiteurs des kinases
EP1469850B1 (fr)	2002-01-02	2013-01-02	Versi Group, LLC	Methode de traitement de dysfonctions sexuelles au moyen de composes d'agoniste du recepteur delta opioide
TWI263497B (en) *	2002-03-29	2006-10-11	Lilly Co Eli	Pyridinoylpiperidines as 5-HT1F agonists
EP1689721B1 (fr) *	2003-11-26	2010-07-14	Pfizer Products Inc.	Derives d'aminopyrazole en tant qu'inhibiteurs de la gsk-3
EP1737466A1 (fr) *	2004-01-29	2007-01-03	Pfizer Products Inc.	COMBINAISON DE MODULATEURS D'ACIDE GAMMA-AMINOBUTYRIQUE ET D'ANTAGONISTES DU RECEPTEUR 5-HT-1b
EA200601461A1 (ru) *	2004-03-17	2007-02-27	Пфайзер Продактс, Инк.	Новые производные бензил(иден)лактама
BRPI0510942A (pt) *	2004-05-11	2007-07-17	Pfizer Prod Inc	combinação de antipsicóticos atìpicos e antagonistas do receptor 5-ht1b
WO2005113535A2 (fr) *	2004-05-21	2005-12-01	Pfizer Products Inc.	Derives pyrazinylmethyle-lactame
JP2008503559A (ja) *	2004-06-25	2008-02-07	ファイザー・プロダクツ・インク	Ｃｎｓ障害を治療するためのピリジルピペラジン
US8012969B2 (en)	2005-01-13	2011-09-06	Ge Healthcare Limited	11C-labeled benzyl-lactam compounds and their use as imaging agents
WO2006106416A1 (fr) *	2005-04-08	2006-10-12	Pfizer Products Inc.	Pyridil-lactams et leur utilisation comme ligands de recepteurs 5-ht1
JP2008543829A (ja) *	2005-06-17	2008-12-04	ファイザー・プロダクツ・インク	セロトニン受容体アンタゴニストとしての１−［６−（１−エチル−１−ヒドロキシ−プロピル）−ピリジン−３−イル］−３−［２−（４−メチル−ピペラジン−１−イル）−ベンジル］−ピロリジン−２−オンの代謝産物
WO2007012964A1 (fr) *	2005-07-25	2007-02-01	Pfizer Products Inc.	Préparation de composés d'alkylpipérazinylphényle par dédoublement classique
WO2007026219A2 (fr) *	2005-08-31	2007-03-08	Pfizer Products Inc.	Composition d'antagonistes du recepteur 5-ht1b servant au traitement d'etats du systeme nerveux central
WO2007026224A2 (fr) *	2005-08-31	2007-03-08	Pfizer Products Inc.	Composition d'antagoniste 5-ht1b pour le traitement de la depression, de l'anxiete et des troubles de la cognition
US20070096411A1 (en) *	2005-11-02	2007-05-03	Rempe Gary L Ii	Device for retaining a kneeling rider on a gliding board
WO2014078568A1 (fr)	2012-11-14	2014-05-22	The Johns Hopkins University	Méthodes et compositions pour le traitement de la schizophrénie
MD3344248T2 (ro)	2015-09-02	2022-10-31	Trevena Inc	Aza-heterociclic cu 6 elemente conținând compuși de modulare a receptorului delta-opioid, metode de utilizare și fabricare a acestora
BR112019016827A2 (pt)	2017-02-17	2020-04-07	Trevena Inc	compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos
US11225487B2 (en)	2017-02-17	2022-01-18	Trevena, Inc.	7-membered aza-heterocyclic containing δ-opioid receptor modulating compounds, methods of using and making the same
WO2020183011A1 (fr)	2019-03-14	2020-09-17	Institut Curie	Inhibiteurs de htr1d et leurs utilisations dans le traitement du cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4078062A (en) *	1976-10-28	1978-03-07	E. R. Squibb & Sons, Inc.	Substituted 2H-1,4-benzothiazin-3(4H)-ones
JPS62116557A (ja) *	1985-11-15	1987-05-28	Takeda Chem Ind Ltd	置換ベンジルラクタム類
US5189179A (en) *	1990-08-29	1993-02-23	Merrell Dow Pharmaceuticals Inc.	Serotonin 5ht1a agonists
EP0533268B1 (fr)	1991-09-18	2001-08-16	Glaxo Group Limited	Dérivés de benzanilide comme 5-HT1D antagonistes
EP0607334B1 (fr) *	1991-10-11	1997-07-30	The Du Pont Merck Pharmaceutical Company	Urees cycliques et analogues utiles en tant qu'inhibiteurs de la protease retrovirale
US5436246A (en)	1992-09-17	1995-07-25	Merrell Dow Pharmaceuticals Inc.	Serotonin receptor agents
GB9410512D0 (en) *	1994-05-25	1994-07-13	Smithkline Beecham Plc	Novel treatment
US5880141A (en) *	1995-06-07	1999-03-09	Sugen, Inc.	Benzylidene-Z-indoline compounds for the treatment of disease
US6467084B1 (en) *	1999-12-16	2002-10-15	Emware, Inc.	Systems and methods for reprogramming an embedded device with program code using relocatable program code

1997
- 1997-02-03 AT AT97900717T patent/ATE302182T1/de not_active IP Right Cessation
- 1997-02-03 TR TR1998/01929T patent/TR199801929T2/xx unknown
- 1997-02-03 BR BR9708581A patent/BR9708581A/pt not_active Application Discontinuation
- 1997-02-03 NZ NZ325914A patent/NZ325914A/en unknown
- 1997-02-03 KR KR1019980707713A patent/KR100305071B1/ko not_active IP Right Cessation
- 1997-02-03 CZ CZ19983052A patent/CZ293628B6/cs not_active IP Right Cessation
- 1997-02-03 EA EA199800771A patent/EA001485B1/ru not_active IP Right Cessation
- 1997-02-03 ES ES97900717T patent/ES2246058T3/es not_active Expired - Lifetime
- 1997-02-03 HU HU9902160A patent/HUP9902160A3/hu unknown
- 1997-02-03 CA CA002249603A patent/CA2249603A1/fr not_active Abandoned
- 1997-02-03 AU AU13170/97A patent/AU706839B2/en not_active Ceased
- 1997-02-03 JP JP09535074A patent/JP3118467B2/ja not_active Expired - Fee Related
- 1997-02-03 CN CN97193251A patent/CN1128788C/zh not_active Expired - Fee Related
- 1997-02-03 DE DE69733996T patent/DE69733996T2/de not_active Expired - Fee Related
- 1997-02-03 US US09/155,215 patent/US6462048B2/en not_active Expired - Fee Related
- 1997-02-03 EP EP97900717A patent/EP0894085B1/fr not_active Expired - Lifetime
- 1997-02-03 SK SK1314-98A patent/SK131498A3/sk unknown
- 1997-02-03 IL IL12537797A patent/IL125377A/xx not_active IP Right Cessation
- 1997-02-03 WO PCT/IB1997/000076 patent/WO1997036867A1/fr active IP Right Grant
- 1997-02-03 PL PL97329170A patent/PL329170A1/xx unknown
- 1997-02-04 TW TW086101295A patent/TW413679B/zh active
- 1997-02-06 HN HN1997000023A patent/HN1997000023A/es unknown
- 1997-03-02 UA UA98095077A patent/UA70284C2/uk unknown
- 1997-03-13 CO CO97013714A patent/CO4650033A1/es unknown
- 1997-03-21 UY UY24498A patent/UY24498A1/es not_active IP Right Cessation
- 1997-03-25 AR ARP970101200A patent/AR006390A1/es not_active Application Discontinuation
- 1997-03-26 DZ DZ970045A patent/DZ2198A1/fr active
- 1997-03-26 TN TNTNSN97056A patent/TNSN97056A1/fr unknown
- 1997-03-26 HR HR60/015,134A patent/HRP970175A2/hr not_active Application Discontinuation
- 1997-03-26 MA MA24535A patent/MA26425A1/fr unknown
- 1997-03-27 ZA ZA972690A patent/ZA972690B/xx unknown
- 1997-03-27 AP APAP/P/1997/000955A patent/AP824A/en active
- 1997-03-27 YU YU11997A patent/YU11997A/sh unknown
- 1997-03-27 ID IDP971025A patent/ID17781A/id unknown
- 1997-03-28 MY MYPI97001340A patent/MY118498A/en unknown
1998
- 1998-07-29 IS IS4813A patent/IS4813A/is unknown
- 1998-09-16 OA OA9800170A patent/OA10879A/en unknown
- 1998-09-24 BG BG102791A patent/BG64176B1/bg unknown
- 1998-09-28 NO NO19984513A patent/NO312957B1/no unknown
1999
- 1999-10-13 HK HK99104493A patent/HK1019446A1/xx not_active IP Right Cessation
2002
- 2002-08-15 US US10/219,692 patent/US6924289B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
HRP970175A2 (en)	1998-12-31
AR006390A1 (es)	1999-08-25
ES2246058T3 (es)	2006-02-01
TW413679B (en)	2000-12-01
BR9708581A (pt)	1999-08-03
ATE302182T1 (de)	2005-09-15
TNSN97056A1 (fr)	2005-03-15
US20020028821A1 (en)	2002-03-07
DZ2198A1 (fr)	2002-12-02
DE69733996D1 (de)	2005-09-22
US6462048B2 (en)	2002-10-08
NO312957B1 (no)	2002-07-22
WO1997036867A1 (fr)	1997-10-09
HUP9902160A2 (hu)	1999-11-29
OA10879A (en)	2001-10-05
CO4650033A1 (es)	1998-09-03
US20030027812A1 (en)	2003-02-06
HUP9902160A3 (en)	2001-02-28
IL125377A (en)	2005-07-25
EA199800771A1 (ru)	1999-06-24
MY118498A (en)	2004-11-30
BG102791A (en)	1999-11-30
AP824A (en)	2000-04-28
AU1317097A (en)	1997-10-22
PL329170A1 (en)	1999-03-15
JPH11506472A (ja)	1999-06-08
ID17781A (id)	1998-01-29
US6924289B2 (en)	2005-08-02
EA001485B1 (ru)	2001-04-23
NO984513D0 (no)	1998-09-28
UY24498A1 (es)	2000-09-29
DE69733996T2 (de)	2006-07-20
BG64176B1 (bg)	2004-03-31
NO984513L (no)	1998-09-28
YU11997A (sh)	1999-09-27
KR20000005083A (ko)	2000-01-25
IS4813A (is)	1998-07-29
CA2249603A1 (fr)	1997-10-09
IL125377A0 (en)	1999-03-12
CN1214043A (zh)	1999-04-14
CZ305298A3 (cs)	1999-07-14
EP0894085A1 (fr)	1999-02-03
UA70284C2 (en)	2004-10-15
JP3118467B2 (ja)	2000-12-18
ZA972690B (en)	1998-09-28
KR100305071B1 (ko)	2001-12-12
EP0894085B1 (fr)	2005-08-17
HK1019446A1 (en)	2000-02-11
CN1128788C (zh)	2003-11-26
HN1997000023A (es)	1997-06-05
AP9700955A0 (en)	1997-04-30
TR199801929T2 (xx)	1998-12-21
AU706839B2 (en)	1999-06-24
SK131498A3 (en)	2000-09-12
CZ293628B6 (cs)	2004-06-16
NZ325914A (en)	1999-09-29

Publication	Publication Date	Title
MA26425A1 (fr)	2004-12-20	Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26424A1 (fr)	2004-12-20	Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26433A1 (fr)	2004-12-20	Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26468A1 (fr)	2004-12-20	Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26686A1 (fr)	2004-12-20	Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26479A1 (fr)	2004-12-20	Derives de nicotinamide, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26432A1 (fr)	2004-12-20	Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26558A1 (fr)	2004-12-20	Derives nouveaux de 6-0-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26559A1 (fr)	2004-12-20	Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
MA26680A1 (fr)	2004-12-20	Derives de quinoleine-2-one a substituant alcynyle nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26438A1 (fr)	2004-12-20	Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26465A1 (fr)	2004-12-20	Derives de quinoleine et derives de quinazoline nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2780057B1 (fr)	2002-09-13	Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26439A1 (fr)	2004-12-20	Derives d'indazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
MA26687A1 (fr)	2004-12-20	4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2735777B1 (fr)	1997-09-12	Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
MA23831A1 (fr)	1996-10-01	Derives de quinazoline, procede pour leur preparation et composition les contenant
MA26414A1 (fr)	2004-12-20	Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.
MA26471A1 (fr)	2004-12-20	Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26505A1 (fr)	2004-12-20	Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26526A1 (fr)	2004-12-20	Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26740A1 (fr)	2004-12-20	Derives de 13-methyl-erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant